Scribd
Upload
806 views3 pages

Double Marker Test

The laboratory investigation report for Mrs. Komal indicates an intermediate risk for Down's Syndrome (T21) and low risks for Edwards Syndrome (T18) and Patau's Syndrome (T13) based on serum double marker tests. The report was amended and supersedes a previous report, with a recommendation for confirmation of positive results through amniotic fluid testing. The tests were conducted at 12 weeks and 1 day of gestation, and the report includes various clinical details and risk assessments.

Uploaded by

shadab alam
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
806 views3 pages

Double Marker Test

The laboratory investigation report for Mrs. Komal indicates an intermediate risk for Down's Syndrome (T21) and low risks for Edwards Syndrome (T18) and Patau's Syndrome (T13) based on serum double marker tests. The report was amended and supersedes a previous report, with a recommendation for confirmation of positive results through amniotic fluid testing. The tests were conducted at 12 weeks and 1 day of gestation, and the report includes various clinical details and risk assessments.

Uploaded by

shadab alam
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Laboratory Investigation Report

Patient Name : Mrs. Komal Centre : 1968 - Dr. Nanda Diagnostic Centre
Age/Gender : 32 Y 9 M 6 D /F OP/IP No :/
Max ID/Mobile : ML01453170/ Collection Date/Time : 30/Sep/2021 06:39PM
Lab ID : 1720092100111 Receiving Date : 01/Oct/2021
Ref Doctor : Dr. Reporting Date : 05/Oct/2021
Passport No. :

Clinical Biochemistry Special


Test Name Result Unit Bio Ref Interval

PDF Attached
Double Marker*, Serum
DELFIA

Downs Syndrome Risk(T21) Intermediate


Edwards Syndrome Risk(T18) Low Risk
Pataus Syndrome Risk(T13) Low Risk

Comment:- Amended Report


This report supersedes the previous report verified on 04-10-2021

Comment Statistical Evaluation has been done using Life Cycle Screening management software
7KH6FUHHQLQJWHVWLVEDVHGRQ%LRFKHPLFDOUHVXOWV3DWLHQW¶VKLVWRU\DQGSRSXODWLRQGDWD7KLVLQGLFDWHVDKLJKRUORZULVNFDWHJRU\WHVW
Few cases of false positivity can occur in this screening test. Confirmation of screen positive results is recommended in the amniotic fluid.
The test is valid between 11th and 13th weeks 6 days of gestation.

Kindly correlate with clinical findings


*** End Of Report ***

Page 1 of 1

6,11R6%7HVW3HUIRUPHGDW0D[+RVSLWDO6DNHW066+3UHVV(QFODYH5RDG0DQGLU0DUJ6DNHW1HZ'HOKL'HOKL
%RRNLQJ&HQWUH'U1DQGD'LDJQRVWLF&HQWUH&2XWHU5LQJ5RDGQHDU5DPD0DUNHW%ORFN&6DUDVZDWL9LKDU3LWDP3XUD'HOKL

7KHDXWKHQWLFLW\RIWKHUHSRUWFDQEHYHULILHGE\VFDQQLQJWKH45&RGHRQWRSRIWKHSDJH
PATIENT REPORT - KOMAL 05/10/2021

Requestor: -, -
REQUESTOR TYPE: REQUESTOR: DOCTOR: FACILITY:
- - - -
REQUESTOR CODE: REQUESTOR PHONE 1:
- -

Patient ML01453170: -, KOMAL


PATIENT ID: LAST NAME: FIRST NAME: BIRTH DATE:
ML01453170 - KOMAL 24/12/1988
ETHNICITY: PHONE NO. 1: ADDRESS 1: CITY:
Asian - - -
POSTAL CODE:
-

Pregnancy, Calculated EDD: 13/04/2022 (MAEDD: 33.3)


MAEDD: CALCULATED EDD: GEST. DATE: SELECTED GEST. METHOD:
33.3 13/04/2022 07/07/2021 CRL
LMP DATE: SMOKING STATUS: INSULIN DEP. DIABETIC: NO. OF FETUSES:
09/07/2021 Non smoker No 1
MONOZYGOUS: CHORIONICITY: CORRECTED BY CHORIONICITY: FERTILIZATION DATE:
No - - -
HEIGHT [CM]: MATERNAL WEIGHT [KG]: DIABETES TYPE II: INSULIN TREATMENT FOR TYPE II DIABETES:
- - - -
CONCEPTION METHOD: MOTHER OF PATIENT HAD PRE-ECLAMPSIA: CHRONIC HYPERTENSION: SYSTEMIC LUPUS ERYTHEMATOSUS:
- - - -
ANTI-PHOSPHOLIPID SYNDROME: PAST NO. OF PREGNANCIES ≥ 24 WEEKS: PREV. PREG. PRE-ECLAMPSIA: PREV. PREG. DELIVERY DATE:
- - - -
INTER-PREGNANCY INTERVAL [YEARS]: PREV. PREG. GEST. AT DELIVERY: PREV. PREG. BABY WEIGHT [G]: BIRTH WEIGHT Z-SCORE:
- 0w0d - -
ASSISTANCE METHOD: TRANSFER DATE: EGG EXTRACTION DATE: EGG DONOR DOB:
- - - -
AGE AT EXTRACTION: PAST T21 - DOWN'S SYNDROME: PAST T18 - EDWARDS' SYNDROME: PAST T13 - PATAU'S SYNDROME:
- - - -
PAST CDLS - CORNELIA DE LANGE SYNDROME: PAST SLOS - SMITH-LEMLI-OPITZ SYNDROME: PAST TR - TRIPLOIDY: PAST TS - TURNER'S SYNDROME:
- - - -
RISK ASSESSED: SCREENING PROTOCOL:
At term Screening_4.0

Biochemistry
SAMPLE ID: SPECIMEN COLLECTED: WEIGHT [KG]: GEST. AT SAMPLE DATE (W + D):
SB1287637 30/09/2021 48 12 w 1 d
SAMPLE TYPE:
-

Ultrasound
SCAN DATE: CRL IN MM: BPD IN MM: HC IN MM:
30/09/2021 56.4 - -
GEST. AT SAMPLE DATE (W + D): CRL (#2) IN MM: BPD (#2) IN MM: HC (#2) IN MM:
12 w 1 d - - -
GEST. AT MANUAL ENTRY (W + D): WEIGHT [KG]: SAMPLE TYPE:
0w0d 48 -

Tests

REPORT CREATED BY: REPORT CREATED AT:


05/10/2021 11:28
Priyanka Bhatt

1/2
PATIENT REPORT - KOMAL 05/10/2021
TEST SAMPLE ID DATE GEST. AT SAMPLE VALUE UNIT CORR. MOM WEIGHT [KG]
DATE (W + D)
hCGb (Signed) SB1287637 30/09/2021 12 w 1 d 54.65 ng/mL 1.09 48

PAPP-A (Signed) SB1287637 30/09/2021 12 w 1 d 2004.88 mU/L 0.57 48

NB (Signed) - 30/09/2021 12 w 1 d Absent - - 48

NT (Signed) - 30/09/2021 12 w 1 d 0.9 mm 0.72 48

Risks, Risk assessed: At term


RISK NAME: RISK RESULT: RISK: TWIN RISK RESULT: TWIN RISK: AGE RISK: CUT-OFF:
T21 (Calculated) Intermediate 1:198 - - 1:596 1:100
RISK NAME: RISK RESULT: RISK: TWIN RISK RESULT: TWIN RISK: AGE RISK: CUT-OFF:
T18 (Calculated) Low 1:100000 - - 1:5364 1:500
RISK NAME: RISK RESULT: RISK: TWIN RISK RESULT: TWIN RISK: AGE RISK: CUT-OFF:
T13 (Calculated) Low 1:100000 - - 1:16102 1:500

PLEASE NOTE:

REPORT CREATED BY: REPORT CREATED AT:


05/10/2021 11:28
Priyanka Bhatt

2/2

You might also like